Review



human hcc cell lines snu387  (ATCC)


Bioz Verified Symbol ATCC is a verified supplier
Bioz Manufacturer Symbol ATCC manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    ATCC human hcc cell lines snu387
    Smyd3-ASO treatment inhibits proliferation rates and colony formation ability of human hepatocellular carcinoma cell lines (A) Growth curves of HuH7, <t>SNU387,</t> HLF, SNU398, SNU423, and SNU449 cell lines treated with 0.2 μM control-ASO (blue lines) or hSmyd3-ASO-1 (red lines). The cells were pretreated with the ASOs for one passage before plating. Data points represent mean values of the fold increase in cell numbers compared to time 0 (12 hr after seeding) and SEM from 3 independent experiments. (B) Colony formation capacity of HLF, SNU398, SNU423, SNU449, and HuH7 cell lines treated with 0.2 μM control-ASO or hSmyd3-ASO-1 or hSmyd3-ASO-2. The cells were seeded at a density of 1000 cells per 100 mm plate and fixed after 18-22 days. ASO-containing medium was replaced every 3 days. Bars represent the average number of colonies per plate and SEM from 3 experiments. See also .
    Human Hcc Cell Lines Snu387, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 308 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human hcc cell lines snu387/product/ATCC
    Average 96 stars, based on 308 article reviews
    human hcc cell lines snu387 - by Bioz Stars, 2026-03
    96/100 stars

    Images

    1) Product Images from "Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth"

    Article Title: Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth

    Journal: iScience

    doi: 10.1016/j.isci.2021.102473

    Smyd3-ASO treatment inhibits proliferation rates and colony formation ability of human hepatocellular carcinoma cell lines (A) Growth curves of HuH7, SNU387, HLF, SNU398, SNU423, and SNU449 cell lines treated with 0.2 μM control-ASO (blue lines) or hSmyd3-ASO-1 (red lines). The cells were pretreated with the ASOs for one passage before plating. Data points represent mean values of the fold increase in cell numbers compared to time 0 (12 hr after seeding) and SEM from 3 independent experiments. (B) Colony formation capacity of HLF, SNU398, SNU423, SNU449, and HuH7 cell lines treated with 0.2 μM control-ASO or hSmyd3-ASO-1 or hSmyd3-ASO-2. The cells were seeded at a density of 1000 cells per 100 mm plate and fixed after 18-22 days. ASO-containing medium was replaced every 3 days. Bars represent the average number of colonies per plate and SEM from 3 experiments. See also .
    Figure Legend Snippet: Smyd3-ASO treatment inhibits proliferation rates and colony formation ability of human hepatocellular carcinoma cell lines (A) Growth curves of HuH7, SNU387, HLF, SNU398, SNU423, and SNU449 cell lines treated with 0.2 μM control-ASO (blue lines) or hSmyd3-ASO-1 (red lines). The cells were pretreated with the ASOs for one passage before plating. Data points represent mean values of the fold increase in cell numbers compared to time 0 (12 hr after seeding) and SEM from 3 independent experiments. (B) Colony formation capacity of HLF, SNU398, SNU423, SNU449, and HuH7 cell lines treated with 0.2 μM control-ASO or hSmyd3-ASO-1 or hSmyd3-ASO-2. The cells were seeded at a density of 1000 cells per 100 mm plate and fixed after 18-22 days. ASO-containing medium was replaced every 3 days. Bars represent the average number of colonies per plate and SEM from 3 experiments. See also .

    Techniques Used: Control


    Figure Legend Snippet:

    Techniques Used: Recombinant, Protease Inhibitor, Reverse Transcription, SYBR Green Assay, Modification, Software



    Similar Products

    96
    ATCC human hcc cell lines snu387
    Smyd3-ASO treatment inhibits proliferation rates and colony formation ability of human hepatocellular carcinoma cell lines (A) Growth curves of HuH7, <t>SNU387,</t> HLF, SNU398, SNU423, and SNU449 cell lines treated with 0.2 μM control-ASO (blue lines) or hSmyd3-ASO-1 (red lines). The cells were pretreated with the ASOs for one passage before plating. Data points represent mean values of the fold increase in cell numbers compared to time 0 (12 hr after seeding) and SEM from 3 independent experiments. (B) Colony formation capacity of HLF, SNU398, SNU423, SNU449, and HuH7 cell lines treated with 0.2 μM control-ASO or hSmyd3-ASO-1 or hSmyd3-ASO-2. The cells were seeded at a density of 1000 cells per 100 mm plate and fixed after 18-22 days. ASO-containing medium was replaced every 3 days. Bars represent the average number of colonies per plate and SEM from 3 experiments. See also .
    Human Hcc Cell Lines Snu387, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human hcc cell lines snu387/product/ATCC
    Average 96 stars, based on 1 article reviews
    human hcc cell lines snu387 - by Bioz Stars, 2026-03
    96/100 stars
      Buy from Supplier

    90
    Keygen Biotech human hcc cell lines snu387
    Smyd3-ASO treatment inhibits proliferation rates and colony formation ability of human hepatocellular carcinoma cell lines (A) Growth curves of HuH7, <t>SNU387,</t> HLF, SNU398, SNU423, and SNU449 cell lines treated with 0.2 μM control-ASO (blue lines) or hSmyd3-ASO-1 (red lines). The cells were pretreated with the ASOs for one passage before plating. Data points represent mean values of the fold increase in cell numbers compared to time 0 (12 hr after seeding) and SEM from 3 independent experiments. (B) Colony formation capacity of HLF, SNU398, SNU423, SNU449, and HuH7 cell lines treated with 0.2 μM control-ASO or hSmyd3-ASO-1 or hSmyd3-ASO-2. The cells were seeded at a density of 1000 cells per 100 mm plate and fixed after 18-22 days. ASO-containing medium was replaced every 3 days. Bars represent the average number of colonies per plate and SEM from 3 experiments. See also .
    Human Hcc Cell Lines Snu387, supplied by Keygen Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human hcc cell lines snu387/product/Keygen Biotech
    Average 90 stars, based on 1 article reviews
    human hcc cell lines snu387 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    90
    Korean Cell Line Bank human hcc cell lines snu387
    Smyd3-ASO treatment inhibits proliferation rates and colony formation ability of human hepatocellular carcinoma cell lines (A) Growth curves of HuH7, <t>SNU387,</t> HLF, SNU398, SNU423, and SNU449 cell lines treated with 0.2 μM control-ASO (blue lines) or hSmyd3-ASO-1 (red lines). The cells were pretreated with the ASOs for one passage before plating. Data points represent mean values of the fold increase in cell numbers compared to time 0 (12 hr after seeding) and SEM from 3 independent experiments. (B) Colony formation capacity of HLF, SNU398, SNU423, SNU449, and HuH7 cell lines treated with 0.2 μM control-ASO or hSmyd3-ASO-1 or hSmyd3-ASO-2. The cells were seeded at a density of 1000 cells per 100 mm plate and fixed after 18-22 days. ASO-containing medium was replaced every 3 days. Bars represent the average number of colonies per plate and SEM from 3 experiments. See also .
    Human Hcc Cell Lines Snu387, supplied by Korean Cell Line Bank, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human hcc cell lines snu387/product/Korean Cell Line Bank
    Average 90 stars, based on 1 article reviews
    human hcc cell lines snu387 - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Smyd3-ASO treatment inhibits proliferation rates and colony formation ability of human hepatocellular carcinoma cell lines (A) Growth curves of HuH7, SNU387, HLF, SNU398, SNU423, and SNU449 cell lines treated with 0.2 μM control-ASO (blue lines) or hSmyd3-ASO-1 (red lines). The cells were pretreated with the ASOs for one passage before plating. Data points represent mean values of the fold increase in cell numbers compared to time 0 (12 hr after seeding) and SEM from 3 independent experiments. (B) Colony formation capacity of HLF, SNU398, SNU423, SNU449, and HuH7 cell lines treated with 0.2 μM control-ASO or hSmyd3-ASO-1 or hSmyd3-ASO-2. The cells were seeded at a density of 1000 cells per 100 mm plate and fixed after 18-22 days. ASO-containing medium was replaced every 3 days. Bars represent the average number of colonies per plate and SEM from 3 experiments. See also .

    Journal: iScience

    Article Title: Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth

    doi: 10.1016/j.isci.2021.102473

    Figure Lengend Snippet: Smyd3-ASO treatment inhibits proliferation rates and colony formation ability of human hepatocellular carcinoma cell lines (A) Growth curves of HuH7, SNU387, HLF, SNU398, SNU423, and SNU449 cell lines treated with 0.2 μM control-ASO (blue lines) or hSmyd3-ASO-1 (red lines). The cells were pretreated with the ASOs for one passage before plating. Data points represent mean values of the fold increase in cell numbers compared to time 0 (12 hr after seeding) and SEM from 3 independent experiments. (B) Colony formation capacity of HLF, SNU398, SNU423, SNU449, and HuH7 cell lines treated with 0.2 μM control-ASO or hSmyd3-ASO-1 or hSmyd3-ASO-2. The cells were seeded at a density of 1000 cells per 100 mm plate and fixed after 18-22 days. ASO-containing medium was replaced every 3 days. Bars represent the average number of colonies per plate and SEM from 3 experiments. See also .

    Article Snippet: The human HCC cell lines SNU387 (from grade IV/V pleomorphic HCC), SNU398, SNU423 (from grade III/IV pleomorphic HCC) and SNU449 (from grade II-IV HCC) were from ATCC, HuH7 and HLF cells were from Japanese Cancer Research Foundation (JCRF).

    Techniques: Control

    Journal: iScience

    Article Title: Targeting Smyd3 by next-generation antisense oligonucleotides suppresses liver tumor growth

    doi: 10.1016/j.isci.2021.102473

    Figure Lengend Snippet:

    Article Snippet: The human HCC cell lines SNU387 (from grade IV/V pleomorphic HCC), SNU398, SNU423 (from grade III/IV pleomorphic HCC) and SNU449 (from grade II-IV HCC) were from ATCC, HuH7 and HLF cells were from Japanese Cancer Research Foundation (JCRF).

    Techniques: Recombinant, Protease Inhibitor, Reverse Transcription, SYBR Green Assay, Modification, Software